Daily 2000 IU Vitamin D3 Safe Strategy to Bridge Deficiency Gap in Pregnancy: Suggests Study
A recent study published in the Indian Journal of Nutrition and Dietetics in 2025 evaluates whether daily supplementation with 2,000 International Units (IU) of vitamin D3 can safely achieve maternal repletion to effectively bridge the staggering 60% to 80% deficiency gap prevalent in the community.
Pregnancy increases vitamin D requirements to support maternal and fetal health, yet vitamin D deficiency (VDD) remains a global epidemic linked to adverse outcomes such as pre-eclampsia and low birth weight. To address a clinical gap in the safety and efficacy of early high-dose supplementation, Nandini Chopra from Manipal Academy of Higher Education and colleagues at St. John’s Research Institute designed this protocol. The study evaluates whether 2,000 International Units (IU) of vitamin D3 daily can safely achieve repletion in deficient Indian women while simultaneously assessing its impact on the newborn's immunological profile.
Therefore, the open-label trial at St. John’s Medical College Hospital involves 200 vitamin D-deficient pregnant women receiving 2,000 International Units (IU) of vitamin D3 daily from ≤14 weeks gestation. Excluding patients with chronic morbidities or infections, such as Human Immunodeficiency Virus (HIV) and Hepatitis B Surface Antigen (HBsAg), the study monitors maternal repletion safety and neonatal immunity to support early daily supplementation.
Key Clinical Findings of the Study Include:
High Prevalence Strategy: The study addresses the staggering 60% to 80% vitamin D deficiency rate reported in Indian community-based research by utilizing a robust 2,000 IU daily dose starting in the first trimester.
Repletion Efficacy: This supplemental approach aims to bridge the current research gap by providing clear clinical evidence of effectiveness in restoring vitamin D status when initiated early in the pregnancy journey.
Safety Assurance: A critical clinical takeaway is the rigorous evaluation of safety to ensure that a 2,000 IU dose does not result in hypervitaminosis-D for the expectant mother throughout the intervention.
Immune Modulation: The research investigates whether achieving maternal repletion influences the immune profile of the newborn, potentially offering long-term health benefits to the offspring through improved neonatal immunity.
Risk Mitigation: By optimizing vitamin D levels, the intervention seeks to reduce the incidence of major complications such as gestational diabetes and preterm birth among the studied Indian population.
Chopra N, Adiga V, Karanth S, et al. Vitamin D Supplementation among Deficient Indian Pregnant Women: A Study Protocol. Indian J Nutr Diet. 2025;62(4).
